Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25328557 | 0.89 | CYP1A2 (0.32) | IMPDH2CYP1A2CYP2C19 | |
| SCHEMBL25327981 | 0.89 | CYP1A2 (0.35) | IMPDH2CYP1A2CYP2C19 | |
| SCHEMBL25329094 | 0.88 | IMPDH2 (0.33) | IMPDH2CYP1A2CYP2C19 | |
| SCHEMBL25331642 | 0.88 | CYP1A2 (0.31) | CYP1A2CYP2C19 | |
| SCHEMBL25328390 | 0.85 | CYP1A2 (0.32) | IMPDH2CYP1A2CYP2C19 | |
| SCHEMBL25327716 | 0.84 | PTGS1 (0.32) | — | |
| SCHEMBL25328823 | 0.82 | TSHR (0.31) | — | |
| SCHEMBL25329338 | 0.81 | IMPDH2 (0.44) | IMPDH2 | |
| SCHEMBL25329867 | 0.80 | CYP1A2 (0.37) | IMPDH2CYP1A2CYP2C19 | |
| SCHEMBL25326777 | 0.80 | KDM4E (0.33) | IMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583813-B2 | Polymerization inhibitors | BASF SE (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | RCE1, CABLES1, DPYD | IMPDH2 1168/4885CYP1A2 2252/4885CYP2C19 3538/4885 |
| US-12583813-B2 | Polymerization inhibitors | PTGS1, PTGER1, POT1 | IMPDH2 1852/4885CYP1A2 440/4885CYP2C19 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.